SPRY · ARS Pharmaceuticals, Inc. · Fails to Deliver
$4.01
-0.03 (-0.62%)
At close · Oct 26
Return incl. dividend (before tax)
Market Cap
$397.79M
Shares
99.45M
Volume · Oct 26
557.86K
Avg daily vol (3M)
1.74M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-09-30 | 21,210 | $4.40 | $93,324 |
| 2026-09-29 | 1,628 | $4.13 | $6,724 |
| 2026-09-23 | 16 | $4.48 | $72 |
| 2026-09-22 | 14,945 | $4.35 | $65,011 |
| 2026-09-21 | 21 | $4.11 | $86 |
| 2026-09-18 | 85 | $4.15 | $353 |
| 2026-09-17 | 901 | $4.17 | $3,757 |
| 2026-09-16 | 1,398 | $4.25 | $5,942 |
| 2026-09-15 | 1,398 | $4.50 | $6,291 |
| 2026-09-14 | 1,669 | $4.76 | $7,944 |
| 2026-09-11 | 52,920 | $5.06 | $267,775 |
| 2026-09-09 | 31,783 | $5.39 | $171,310 |
| 2026-09-08 | 58,983 | $5.62 | $331,484 |
| 2026-09-04 | 99,740 | $5.67 | $565,526 |
| 2026-09-03 | 30,842 | $5.82 | $179,500 |
| 2026-09-02 | 46 | $5.77 | $265 |
| 2026-08-31 | 16 | $5.89 | $94 |
| 2026-08-28 | 10,285 | $6.03 | $62,019 |
| 2026-08-26 | 151 | $5.72 | $864 |
| 2026-08-24 | 55 | $5.51 | $303 |
| 2026-08-21 | 55 | $5.51 | $303 |
| 2026-08-20 | 63 | $6.38 | $402 |
| 2026-08-19 | 3,923 | $6.30 | $24,715 |
| 2026-08-18 | 2,043 | $6.24 | $12,748 |
| 2026-08-17 | 49,747 | $5.65 | $281,071 |
| 2026-08-14 | 1,955 | $6.10 | $11,926 |
| 2026-08-11 | 57,061 | $5.91 | $337,231 |
| 2026-08-10 | 94 | $6.16 | $579 |
| 2026-08-07 | 156 | $5.55 | $866 |
| 2026-08-05 | 22 | $5.32 | $117 |
| 2026-08-03 | 16,873 | $5.13 | $86,558 |
| 2026-07-31 | 668 | $5.63 | $3,761 |
| 2026-07-30 | 29,803 | $5.83 | $173,751 |
| 2026-07-29 | 43,831 | $5.67 | $248,522 |
| 2026-07-27 | 1,475 | $5.94 | $8,762 |
Showing 1–35 of 35 settlements
Key facts
CIK
1671858
CUSIP
82835W108
13F (30d)
21 filings
21 filers
Visit website
Investor relations